Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perindopril morning versus evening dosing in essential hypertension (24h ABPM)
2007-007026-22Phase 2Terminated
- Sponsor
- Servier
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of perindopril in essential hypertension (2 arms), sponsored by Servier. Primary endpoint: Mean change in daytime ambulatory diastolic blood pressure. Started Mar 2008; status: terminated.
02
Drugs
perindopril
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2007-007026-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007026-22.